isoxazoles has been researched along with Thrombopenia in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alibhai, D; Aungraheeta, MR; Burley, K; Collins, J; Cornish, N; Downes, K; FitzGibbon, L; Greene, D; Mumford, AD; Turro, E; Westbury, SK | 1 |
| Fowler, N; Hagemeister, F; Knickerbocker, J; Kwak, L; Nastoupil, L; Oki, Y; Romaguera, J; Samaniego, F; Westin, J; Younes, A | 1 |
| Huang, KY; Lai, NS; Liu, SQ; Lu, MC; Tung, CH; Yin, WY; Yu, CL | 1 |
| Barrett, YC; Billheimer, JT; Cromley, DA; Daly, RN; Ebling, W; He, B; Hollis, GF; Hua, TA; Kieras, CJ; Pedicord, DL; Pieniaszek, HJ; Rossi, RJ; Seiffert, D; Sferruzza, A; Stein, RB; Stern, AM; Wynn, R | 1 |
| Billheimer, JT; Breth, L; Dicker, I; Hollis, GF; O'Neil, K; Pedicord, DL; Seiffert, D; Stern, AM; Wynn, R | 1 |
| Calcino, LJ; Hill, RL; McEwen, J; Purcell, PM; Riley, CG | 1 |
| Ahmad, S; Mousa, SA | 1 |
| Brown, T; Hidalgo, M; Kuhn, JG; MacGovren, JP; Rodriguez, G; Rowinsky, EK; Von Hoff, DD; Weiss, G | 1 |
| Billheimer, JT; Bradley, JD; Cromley, DA; Daly, RN; Dicker, IB; Godonis, HE; Gorko, MA; Grimminger, LC; He, B; Hollis, GF; Kieras, CJ; Pedicord, DL; Seiffert, D; Spitz, SM; Stern, AM; Thomas, BE; Wynn, R; Zolotarjova, NI | 1 |
| Eisenhauer, E; Evans, WK; Maroun, JA; Stewart, DJ; Verma, S | 1 |
3 trial(s) available for isoxazoles and Thrombopenia
| Article | Year |
|---|---|
Experience with HSP90 inhibitor AUY922 in patients with relapsed or refractory non-Hodgkin lymphoma.
Topics: Antineoplastic Agents; Diarrhea; Drug Administration Schedule; Edema; Fatigue; Female; Gene Expression; HSP90 Heat-Shock Proteins; Humans; Isoxazoles; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Peripheral; Male; Recurrence; Remission Induction; Resorcinols; Retrospective Studies; Survival Analysis; Thrombocytopenia; Treatment Outcome | 2015 |
Prospective testing for drug-dependent antibodies reduces the incidence of thrombocytopenia observed with the small molecule glycoprotein IIb/IIIa antagonist roxifiban: implications for the etiology of thrombocytopenia.
Topics: Amidines; Autoantibodies; Blood Platelets; Humans; Incidence; Isoxazoles; Platelet Glycoprotein GPIIb-IIIa Complex; Retrospective Studies; Thrombocytopenia; Time Factors; Vascular Diseases | 2003 |
A Phase I and pharmacological study of the glutamine antagonist acivicin with the amino acid solution aminosyn in patients with advanced solid malignancies.
Topics: Adult; Aged; Amino Acids; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Electrolytes; Female; Glucose; Glutamine; Humans; Isoxazoles; Male; Middle Aged; Neoplasms; Parenteral Nutrition Solutions; Solutions; Thrombocytopenia; Treatment Outcome | 1998 |
7 other study(ies) available for isoxazoles and Thrombopenia
| Article | Year |
|---|---|
Monoallelic loss-of-function THPO variants cause heritable thrombocytopenia.
Topics: Humans; Isoxazoles; Thrombocytopenia; Thrombopoietin | 2020 |
Increased prevalence of polyomavirus BK viruria that correlates with thrombocytopenia in patients with systemic lupus erythematosus on intensive immunosuppressive therapy.
Topics: Adult; Antiviral Agents; BK Virus; Female; Humans; Immunosuppression Therapy; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Male; Middle Aged; Polyomavirus Infections; Prevalence; Risk Factors; Thrombocytopenia; Urine; Young Adult | 2009 |
CD32-dependent platelet activation by a drug-dependent antibody to glycoprotein IIb/IIIa antagonists.
Topics: Amidines; Animals; Antibodies, Monoclonal; Blood Platelets; Cysteine Endopeptidases; Humans; In Vitro Techniques; Isoxazoles; Mice; Neoplasm Proteins; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, IgG; Thrombocytopenia | 2003 |
The incidence of pancytopenia in patients taking leflunomide alone or with methotrexate.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 and over; Anemia; Antirheumatic Agents; Australia; Carbamazepine; Child; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization Review; Female; Humans; Incidence; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Neutropenia; Organogold Compounds; Pancytopenia; Thrombocytopenia | 2007 |
Platelet GPIIb/IIIa antagonist, XV459, in heparin-induced thrombocytopenia.
Topics: Amino Acids; Cells, Cultured; Heparin; Humans; Isoxazoles; Kruppel-Like Transcription Factors; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Repressor Proteins; Sensitivity and Specificity; Thrombocytopenia | 2007 |
Evidence that thrombocytopenia observed in humans treated with orally bioavailable glycoprotein IIb/IIIa antagonists is immune mediated.
Topics: Administration, Oral; Amidines; Animals; Antibodies; Biological Availability; Clinical Trials, Phase II as Topic; Enzyme-Linked Immunosorbent Assay; Epitopes; Humans; Isoxazoles; Kinetics; Pan troglodytes; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Conformation; Sensitivity and Specificity; Thrombocytopenia | 2002 |
Phase I study of acivicin and cisplatin in non-small-cell lung cancer. A National Cancer Institute of Canada study.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Canada; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Drug Evaluation; Female; Government Agencies; Humans; Isoxazoles; Kidney; Lung Neoplasms; Male; Middle Aged; Remission Induction; Thrombocytopenia | 1990 |